Therefore, we used gene expression data following the individual and combined overexpression of GATA3 and FOXA1 in the presence and absence of PPARɣ agonist to identify additional transcriptional regulators that may play a role in the activation of a luminal bladder cancer-specific gene expression. The gene discussed is GATA3; the disease is urinary bladder carcinoma.